Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2024-12-11 2024-12-11
Drug Identification Number 01902652 01902652
Brand name RETROVIR (AZT) RETROVIR (AZT)
Common or Proper name Zidovudine Syrup Zidovudine Syrup
Company Name VIIV HEALTHCARE ULC VIIV HEALTHCARE ULC
Ingredients ZIDOVUDINE ZIDOVUDINE
Strength(s) 50MG 50MG
Dosage form(s) SYRUP SYRUP
Route of administration ORAL ORAL ORAL ORAL
Packaging size 240 ml 240 ml
ATC code J05AF J05AF
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2024-11-25 2024-11-25
Estimated end date
Actual end date 2024-12-09 2024-12-09
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments For emergency supply, contact GSK Customer Service at 1-800-387-7374 or cacsu@gsk.com. For emergency supply, contact GSK Customer Service at 1-800-387-7374 or cacsu@gsk.com.
Health Canada comments